AXT Inc. Earnings Call Balances Growth And Risk

AXT Inc ((AXTI)) has held its Q4 earnings call. Read on for the main highlights of the call.

AXT Inc.’s latest earnings call struck a cautiously optimistic tone, with management highlighting record indium phosphide backlog, accelerating AI and data center demand, and a fully funded capacity expansion plan. These positives were tempered by near‑term headwinds, including lower Q4 revenue, ongoing losses, elevated inventory, and heavy reliance on unpredictable China export permits to convert backlog into revenue.

Backlog Reached New High

AXT reported its indium phosphide backlog climbed above $60.0 million, up from $49.0 million just one quarter earlier. This more than $11.0 million, roughly 22%, increase underpins strong near‑ to medium‑term revenue visibility and shows that underlying demand remains robust despite recent quarterly revenue volatility.

Substantial Cash Raise Strengthens Balance Sheet

The company ended 2025 with $128.4 million in cash, cash equivalents and investments, boosted by a public equity offering that brought in about $93.9 million. This $97.2 million increase in liquidity gives AXT the capital it needs to execute its immediate capacity expansion plans without near‑term balance‑sheet strain.

Clear Demand Drivers in AI and Data Centers

Management emphasized that AI and cloud data center build‑outs are driving demand for indium phosphide substrates. AXT expects sequential revenue growth in Q1, with China data‑center‑related revenue alone projected to grow by more than 60% versus Q4, underscoring how central this trend has become to its growth story.

Capacity Expansion Roadmap

AXT has already added roughly 25% capacity since its prior update and is targeting a doubling of capacity from Q4 2025 levels by the end of 2026. The company pegs the resulting run‑rate potential at about $35 million in quarterly revenue, with about $30 million of near‑term CapEx and a possible additional $100–150 million for greenfield expansion in 2027.

Improved Profitability Trends Year over Year

While still unprofitable, AXT showed notable progress on the bottom line versus last year. Non‑GAAP operating loss narrowed to $2.6 million in Q4 2025 from $5.4 million a year earlier, and non‑GAAP net loss improved to $2.6 million from $4.2 million, reflecting better scale and margin versus 2024.

Diversifying Customer Base and Product Mix

The company continued to broaden its customer roster, particularly for indium phosphide, winning business with Tier 1 laser and optical transceiver manufacturers in China and globally. Its top five customers accounted for about 22.6% of revenue, with no single customer exceeding 10%, reducing concentration risk and supporting more durable growth.

Vertical Integration and Raw Materials Progress

Raw material joint ventures delivered $7.6 million in Q4 revenue, illustrating the strategic role of these operations in AXT’s model. Subsidiary JinMei has begun refining high‑quality indium, tightening control over a critical input for indium phosphide substrates and potentially improving cost and supply security over time.

Q1 Near‑Term Revenue Visibility

Management said it has roughly $26 million of revenue in Q1 that is highly likely to be recognized based on existing permits or shipments not needing export approval. Additional export permits could provide upside, giving investors a clearer sense of near‑term sales even as regulatory variables remain in play.

Sequential and Year‑over‑Year Revenue Decline

Q4 2025 revenue came in at $23.0 million, down from $28.0 million in Q3 and $25.1 million in Q4 2024, reflecting both sequential and year‑over‑year declines. The pullback highlights that AXT’s growth trajectory is not linear and that operational and regulatory friction can overshadow strong demand trends in the short term.

Export Permit Delays Gating Growth

The company reiterated that China export permits are the single largest gating factor for revenue conversion and growth. The process is described as opaque and variable, with some denials requiring resubmission, creating substantial uncertainty around quarter‑to‑quarter shipment timing and reported results.

Continued Quarterly Losses

AXT remained in the red in Q4, posting a non‑GAAP net loss of $2.6 million, or $0.06 per share, and a GAAP net loss of $3.6 million, or $0.08 per share. These results show that, despite year‑over‑year improvement, the company has yet to reach the scale and margin needed for sustained GAAP profitability.

Inventory Elevated and Under Scrutiny

Net inventory rose by about $4.0 million in Q4 to $81.7 million, an area management flagged as a priority to improve. Elevated stock levels can strain working capital and are partly linked to delayed shipments from export permit issues, making inventory reduction an important lever for cash efficiency.

Operating Expense Increase Quarter over Quarter

Non‑GAAP operating expenses increased to $7.8 million in Q4 from $6.5 million in Q3, a 20% rise partly attributed to favorable adjustments in the prior quarter. GAAP operating expenses similarly climbed to $8.8 million from $7.3 million, raising the bar for revenue growth needed to deliver operating leverage.

Geographic Revenue Concentration Risk

Asia Pacific represented 81.5% of Q4 revenue, while North America accounted for just 1.0%, underscoring AXT’s heavy regional concentration. This exposure heightens sensitivity to regulatory and macro risks in China and the broader APAC region, reinforcing the importance of geographic diversification over time.

Gross Margin Pressure Sequentially

Non‑GAAP gross margin slipped to 21.5% in Q4 from 22.6% in Q3, even though it improved from 18.0% a year earlier. The sequential margin pressure, alongside rising operating expenses, shows that scaling to higher utilization and improving mix will be critical for translating strong demand into sustainable profit.

Reliance on Capital Raise for Expansion

The recent equity offering was central to funding AXT’s strengthened cash position and expansion roadmap, highlighting its reliance on capital markets to finance growth. With additional greenfield capacity in 2027 potentially requiring $100–150 million, future expansion could bring further dilution or incremental financing risk if internal cash generation lags.

Forward‑Looking Guidance and Management Priorities

For Q1, management expects about $26 million in revenue that is already visible, with upside tied to additional export permits and growth driven by indium phosphide, especially for China data centers. The company guided to non‑GAAP operating expenses around $9.0 million, a non‑GAAP net loss of $0.02–$0.04 per share, and reiterated a focus on gross‑margin gains, expense discipline, and reducing inventory.

AXT’s earnings call painted a picture of a company sitting on strong secular demand and ample cash to invest, yet still navigating regulatory friction and profitability challenges. Investors will be watching how effectively management converts its growing backlog into revenue, manages export permit risk, and executes its capacity build‑out while moving steadily toward sustainable margins and earnings.